6S1X
X-ray structure of human glutamate carboxypeptidase II (GCPII)-E424M inactive mutant, in complex with a inhibitor KB1160
Summary for 6S1X
Entry DOI | 10.2210/pdb6s1x/pdb |
Descriptor | Glutamate carboxypeptidase 2, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (10 entities in total) |
Functional Keywords | glutamate carboxypeptidase ii (gcpii); naaladase; prostate-specific membrane antigen; urea-based inhibitor, hydrolase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 83425.31 |
Authors | Barinka, C.,Kutil, Z. (deposition date: 2019-06-19, release date: 2020-05-13, Last modification date: 2024-10-23) |
Primary citation | Kim, K.,Kwon, H.,Barinka, C.,Motlova, L.,Nam, S.,Choi, D.,Ha, H.,Nam, H.,Son, S.H.,Minn, I.,Pomper, M.G.,Yang, X.,Kutil, Z.,Byun, Y. Novel beta- and gamma-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen. J.Med.Chem., 63:3261-3273, 2020 Cited by PubMed Abstract: Prostate-specific membrane antigen (PSMA) is an excellent biomarker for the early diagnosis of prostate cancer progression and metastasis. The most promising PSMA-targeted agents in the clinical phase are based on the Lys-urea-Glu motif, in which Lys and Glu are α-(l)-amino acids. In this study, we aimed to determine the effect of β- and γ-amino acids in the S1 pocket on the binding affinity for PSMA. We synthesized and evaluated the β- and γ-amino acid analogues with ()- or ()-configuration with keeping α-(l)-Glu as the S1'-binding pharmacophore. The structure-activity relationship studies identified that compound , a β-amino acid analogue with ()-configuration, exhibited the most potent PSMA inhibitory activity with an IC value of 3.97 nM. The X-ray crystal structure of PSMA in complex with provided a mechanistic basis for the stereochemical preference of PSMA, which can guide the development of future PSMA inhibitors. PubMed: 32097010DOI: 10.1021/acs.jmedchem.9b02022 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.76 Å) |
Structure validation
Download full validation report
